Informing drug discovery: a systematic review of POLG-related disease models

Briefing. Overview of how the risk of bias was assessed
<br>
Supplementary Table 1. PRISMA checklist
<br>
Supplementary Figure 1. PRISMA flow diagram
<br>
Supplementary Table 2. Search strategy 
<br>
Supplementary Table 3. Detailed article inclusion/exclusion criteria
<br>
Supplementary Table 4. Excluded full text articles 
<br>
Supplementary Table 5. Data extracted from all included articles.
<br>
Supplementary Table 6A. The criteria for assessing reporting quality of each article.
<br>
Supplementary Table 6B. The assessment of the reporting quality of each article.
<br>
Supplementary Table 6C. The summarised Assessment of the reporting quality of each article.
<br>
Supplementary Table 6D. The assessment of risk of bias for each model system.
<br>
Updated versions are due to changes made during the review stages to ensure clarity of reporting.